IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v7y2023i2d10.1007_s41669-022-00377-9.html
   My bibliography  Save this article

The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review

Author

Listed:
  • Tiyi Morris

    (University College London)

  • Fiona Aspinal

    (University College London)

  • Jean Ledger

    (University College London)

  • Keyi Li

    (University College London)

  • Manuel Gomes

    (University College London)

Abstract

Background Digital health interventions such as smartphone applications (mHealth) or Internet resources (eHealth) are increasingly used to improve the management of chronic conditions, such as type 2 diabetes mellitus. These digital health interventions can augment or replace traditional health services and may be paid for using healthcare budgets. While the impact of digital health interventions for the management of type 2 diabetes on health outcomes has been reviewed extensively, less attention has been paid to their economic impact. Objective This study aims to critically review existing literature on the impact of digital health interventions for the management of type 2 diabetes on health and social care utilisation and costs. Methods Studies that assessed the impact on health and social care utilisation of digital health interventions for type 2 diabetes were included in the study. We restricted the digital health interventions to information provision, self-management and behaviour management. Four databases were searched (MEDLINE, EMBASE, PsycINFO and EconLit) for articles published between January 2010 and March 2021. The studies were analysed using a narrative synthesis approach. The risk of bias and reporting quality were appraised using the ROBINS-I checklist. Results The review included 22 studies. Overall, studies reported mixed evidence on the impact of digital health interventions on health and social care utilisation and costs, and suggested this impact differs according to the healthcare utilisation component. For example, digital health intervention use was associated with lower medication use and fewer outpatient appointments, whereas evidence on general practitioner visits and inpatient admissions was mixed. Most reviewed studies focus on a single component of healthcare utilisation. Conclusions The review shows no clear evidence of an impact of digital health interventions on health and social care utilisation or costs. Further work is needed to assess the impact of digital health interventions across a broader range of care utilisation components and settings, including social and mental healthcare services. Clinical Trial Registration The study protocol was registered on PROSPERO before searches began in April 2021 (registration number: CRD42020172621).

Suggested Citation

  • Tiyi Morris & Fiona Aspinal & Jean Ledger & Keyi Li & Manuel Gomes, 2023. "The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review," PharmacoEconomics - Open, Springer, vol. 7(2), pages 163-173, March.
  • Handle: RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00377-9
    DOI: 10.1007/s41669-022-00377-9
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-022-00377-9
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1007/s41669-022-00377-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Manuel Gomes & Elizabeth Murray & James Raftery, 2022. "Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice," PharmacoEconomics, Springer, vol. 40(4), pages 367-378, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00377-9. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.